My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 269

    1.

    Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

    Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH.

    Diabetes. 2002 Apr;51(4):1157-65.PMID: 11916939 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

    Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Dräger AM, Doni A, van Hinsbergh VW, Stehouwer CD.

    Diabetologia. 1999 Mar;42(3):351-7.PMID: 10096789 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

    De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.

    J Intern Med. 2005 Jan;257(1):100-9.PMID: 15606381 [PubMed - indexed for MEDLINE]Related articles

    4.

    C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.

    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):593-8.PMID: 11950696 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.

    Schalkwijk CG, Ter Wee PM, Stehouwer CD.

    Ann N Y Acad Sci. 2005 Jun;1043:662-70.PMID: 16037290 [PubMed - indexed for MEDLINE]Related articles

    6.

    Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.

    Spijkerman AM, Gall MA, Tarnow L, Twisk JW, Lauritzen E, Lund-Andersen H, Emeis J, Parving HH, Stehouwer CD.

    Diabet Med. 2007 Sep;24(9):969-76. Epub 2007 Jun 25.PMID: 17593241 [PubMed - indexed for MEDLINE]Related articles

    7.

    Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.

    Knudsen ST, Jeppesen P, Frederiksen CA, Andersen NH, Bek T, Ingerslev J, Mogensen CE, Poulsen PL.

    Diabet Med. 2007 Aug;24(8):911-5. Epub 2007 Jun 8.PMID: 17559428 [PubMed - indexed for MEDLINE]Related articles

    8.

    Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

    Stam F, Schalkwijk CG, van Guldener C, ter Wee PM, Stehouwer CD.

    Nephrol Dial Transplant. 2006 Mar;21(3):677-82. Epub 2005 Dec 5.PMID: 16330467 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.

    Gómez JM, Vila R, Catalina P, Soler J, Badimón L, Sahún M.

    Glycoconj J. 2008 Aug;25(6):573-9. Epub 2008 Mar 18.PMID: 18347976 [PubMed - indexed for MEDLINE]Related articles

    10.

    The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.

    Yudkin JS, Panahloo A, Stehouwer C, Emeis JJ, Bulmer K, Mohamed-Ali V, Denver AE.

    Diabetologia. 2000 Sep;43(9):1099-106.PMID: 11043855 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study.

    van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD.

    Diabetologia. 2005 Jul;48(7):1300-6. Epub 2005 May 26.PMID: 15918015 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.

    Yu Y, Suo L, Yu H, Wang C, Tang H.

    Diabetes Res Clin Pract. 2004 Aug;65(2):95-104.PMID: 15223221 [PubMed - indexed for MEDLINE]Related articles

    13.

    Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.

    Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A.

    Diabetes Care. 1999 Nov;22(11):1865-70.PMID: 10546021 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

    Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

    J Am Soc Nephrol. 2006 Feb;17(2):537-45. Epub 2005 Dec 28.PMID: 16382015 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial.

    Vermeulen EG, Rauwerda JA, van den Berg M, de Jong SC, Schalkwijk C, Twisk JW, Stehouwer CD.

    Eur J Clin Invest. 2003 Mar;33(3):209-15.PMID: 12641538 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.

    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.

    Diabet Med. 2005 Aug;22(8):999-1004.PMID: 16026364 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.

    Christiansen MS, Iversen K, Larsen CT, Goetze JP, Hommel E, Mølvig J, Pedersen BK, Magid E, Feldt-Rasmussen B.

    Scand J Clin Lab Invest. 2009;69(2):272-81.PMID: 18972260 [PubMed - indexed for MEDLINE]Related articles

    18.

    Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.

    Persson F, Rossing P, Hovind P, Stehouwer CD, Schalkwijk CG, Tarnow L, Parving HH.

    Scand J Clin Lab Invest. 2008;68(8):731-8.PMID: 18609080 [PubMed - indexed for MEDLINE]Related articles

    19.

    Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

    Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P.

    Clin J Am Soc Nephrol. 2008 Jul;3(4):976-85. Epub 2008 Apr 16.PMID: 18417746 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus.

    Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ.

    Lancet. 1992 Aug 8;340(8815):319-23.PMID: 1353802 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity